ABSTRACT
OBJECTIVE: To determine the diagnostic yield of endobronchial ultrasound with transbronchial needle aspiration (EBUS-TBNA) and to investigate the number of cervical mediastinoscopies that could be avoided when this technique was used as the initial modality in the invasive mediastinal staging of lung cancer. DESIGN: Retrospective cohort study. METHOD: At the St. Antonius Hospital, Nieuwegein, the Netherlands, results from all patients who had undergone EBUS-TBNA for mediastinal staging in lung cancer from September 2008 to January 2011 were collected. If metastases in the mediastinal lymph nodes had been demonstrated by EBUS-TBNA, no indication for additional mediastinoscopy ensued. The diagnostic yield of EBUS-TBNA as well as the number of mediastinoscopies that had been avoided, were calculated. RESULTS: EBUS-TBNA had been used for mediastinal staging in lung cancer in 77 patients. In 39 of these 77 patients (51%), mediastinal lymph node metastases was found using EBUS-TBNA and mediastinoscopy could thus be avoided. In 9 out of 38 (24%) patients whose EBUS-TBNA cytology results were found to be either benign or not representative, mediastinoscopy or endoscopic ultrasound eventually did reveal mediastinal lymph node metastases. In 13 of these 38 patients (34%), no additional cytologic or histologic testing was performed. Diagnostic yield was calculated for the two scenarios. The sensitivity and negative-predictive values for EBUS-TBNA were 64-81% and 42-76%, respectively. CONCLUSION: In more than 50% of lung cancer patients with suspected mediastinal lymph node metastases, cervical mediastinoscopy can be avoided when EBUS-TBNA is used. This examination is the technique of first choice for the invasive staging of the mediastinum in lung cancer, but it can not replace mediastinoscopy completely.
